[{"ticker":"LLY","name":"Eli Lilly and Company","exchange":"NYSE","sector":"Healthcare","gics_sector":"Healthcare","market_cap":1135107567995,"current_price":1273.4600,"previous_close":1306.69,"price_change":-33.2300,"price_change_pct":-2.54,"day_high":1307.9199,"day_low":1257.6200,"day_open":1304.1500,"avg_volume":3046140,"price_as_of":"2026-10-23T20:00:00+00:00","last_price_update":"2026-10-23T20:16:01.718065+00:00","cs_band":"Mixed","ai_signal":"• The stock's rise appears to reflect optimism around advancements in Alzheimer's disease clinical trials, a key focus area for the company. • The broader healthcare sector is seeing increased attention as over 200 companies advance clinical programs targeting Alzheimer's, highlighting competitive dynamics. • This environment may influence investor sentiment toward companies with strong pipelines in neurodegenerative diseases, potentially impacting sector valuations.","ai_signal_short":"Alzheimer's trial progress and sector advances likely support recent gains.","ai_signal_tone":"positive","ai_signal_history_id":"b2eede74-dce5-4424-9550-3e5c304018f3","ai_signal_updated_at":"2026-10-23T13:30:42.631+00:00","price_kind":"close","adv_tier":3,"ext_price":1278.93,"ext_price_as_of":"2026-10-23T23:57:01.526+00:00","market_session":"closed","has_intraday":true,"delisted_at":null,"successor_ticker":null,"asset_type":"CS","volume":2261329,"pe_ratio":42.41,"dividend_yield":0.0051,"beta_1y":0.238,"avg_volume_30d":2323508,"ratios_as_of":"2026-10-21","ratios_price":1270.75,"sic_code":2834}]